Angiotensin type 2 receptor (AT2R) agonists represent a novel anti-fibrotic strategy, alone or combined with standard therapy, for treating diabetic heart failure.
AT2R agonists are proposed as a novel anti-fibrotic strategy for the treatment of diabetic heart failure.
Absolute Event Rate: 0% vs 0%
R agonists as a novel anti-fibrotic strategy, alone or in combination with standard therapy, for diabetic heart failure.
Li et al. (Thu,) reported a other. Angiotensin type 2 receptor (AT2R) agonists represent a novel anti-fibrotic strategy, alone or combined with standard therapy, for treating diabetic heart failure.